Codexis CDXS Stock
$2.17
2.107721%
Add to favorites
SECTOR
INDUSTRY
COUNTRY
Exchange
Market Cap
$197.70M
LOW - HIGH [24H]
$2.14
-
$2.21
VOLUME [24H]
$63.45K
P/E Ratio
0
Earnings per share
-$0.35
ISIN
US1920051067
Codexis Price Chart
Codexis CDXS Financial and Trading Overview
| Codexis stock price | 2.18 USD |
| Previous Close | 2.43 USD |
| Open | 2.42 USD |
| Bid | 1.75 USD x 200 |
| Ask | 2.85 USD x 200 |
| Day's Range | 2.23 - 2.47 USD |
| 52 Week Range | 0.96 - 3.87 USD |
| Volume | 579.54K USD |
| Avg. Volume | 1.01M USD |
| Market Cap | 204.52M USD |
| Beta (5Y Monthly) | 2.5 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.35 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.58 USD |
CDXS Valuation Measures
| Enterprise Value | 212.28M USD |
| Trailing P/E | N/A |
| Forward P/E | -6.081081 |
| PEG Ratio (5 yr expected) | 13.53 |
| Price/Sales (ttm) | 2.6189275 |
| Price/Book (mrq) | 4.7268906 |
| Enterprise Value/Revenue | 2.718 |
| Enterprise Value/EBITDA | -10.33 |
Trading Information
Codexis Stock Price History
| Beta (5Y Monthly) | 2.5 |
| 52-Week Change | -19.92% |
| S&P500 52-Week Change | 20.36% |
| 52 Week High | 3.87 USD |
| 52 Week Low | 0.96 USD |
| 50-Day Moving Average | 2.54 USD |
| 200-Day Moving Average | 2.02 USD |
CDXS Share Statistics
| Avg. Volume (3 month) | 1.01M USD |
| Avg. Daily Volume (10-Days) | 765.24K USD |
| Shares Outstanding | 90.9M |
| Float | 73.46M |
| Short Ratio | 3.56 |
| % Held by Insiders | 7.40% |
| % Held by Institutions | 74.95% |
| Shares Short | 3.23M |
| Short % of Float | 3.60% |
| Short % of Shares Outstanding | 3.54% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -40.96% |
| Operating Margin (ttm) | -52.74% |
| Gross Margin | 23.83% |
| EBITDA Margin | -26.31% |
Management Effectiveness
| Return on Assets (ttm) | -12.53% |
| Return on Equity (ttm) | -68.89% |
Income Statement
| Revenue (ttm) | 78.09M USD |
| Revenue Per Share (ttm) | 0.88 USD |
| Quarterly Revenue Growth (yoy) | 102.09% |
| Gross Profit (ttm) | 18.61M USD |
| EBITDA | -20550000 USD |
| Net Income Avi to Common (ttm) | -31990000 USD |
| Diluted EPS (ttm) | -0.32 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 65.14M USD |
| Total Cash Per Share (mrq) | 0.72 USD |
| Total Debt (mrq) | 72.9M USD |
| Total Debt/Equity (mrq) | 168.62 USD |
| Current Ratio (mrq) | 5.364 |
| Book Value Per Share (mrq) | 0.476 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -18728000 USD |
| Levered Free Cash Flow (ttm) | -8476750 USD |
Profile of Codexis
| Country | United States |
| State | CA |
| City | Redwood City |
| Address | 200 Penobscot Drive |
| ZIP | 94063 |
| Phone | 650 421 8100 |
| Website | https://www.codexis.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 146 |
Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.
Q&A For Codexis Stock
What is a current CDXS stock price?
Codexis CDXS stock price today per share is 2.18 USD.
How to purchase Codexis stock?
You can buy CDXS shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Codexis?
The stock symbol or ticker of Codexis is CDXS.
Which industry does the Codexis company belong to?
The Codexis industry is Biotechnology.
How many shares does Codexis have in circulation?
The max supply of Codexis shares is 90.9M.
What is Codexis Price to Earnings Ratio (PE Ratio)?
Codexis PE Ratio is now.
What was Codexis earnings per share over the trailing 12 months (TTM)?
Codexis EPS is -0.35 USD over the trailing 12 months.
Which sector does the Codexis company belong to?
The Codexis sector is Healthcare.
Codexis CDXS included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26173.1 USD — |
+0.25
|
1.81B USD — | 26170.86 USD — | 26316.81 USD — | — - | 1.81B USD — |
|
US Tech Global Select Market Com
NQGS
US
|
12854.41 USD — |
+0.31
|
— — | 12847.79 USD — | 12920.04 USD — | — - | — — |
|
US Tech Biotechnology
NBI
US
|
6525.48 USD — |
+0.14
|
— — | 6454.97 USD — | 6525.78 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1248.62 USD — |
+0.59
|
— — | 1233.72 USD — | 1248.71 USD — | — - | — — |
|
US Tech Composite Total Return
XCMP
US
|
32304.12 USD — |
+0.3
|
— — | 32285.29 USD — | 32465.34 USD — | — - | — — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
|
US Tech Industrial
INDS
US
|
12975.72 USD — |
+1.34
|
— — | 12901.02 USD — | 12977.35 USD — | — - | — — |
- {{ link.label }} {{link}}